New Perspectives in Colorectal Cancers Treatment, the Role of MicroRNAs.

Autor:	Belova VA; Division of Biochemistry and Molecular Biology, Siberian State Medical University, Tomsk, Russian Federation., Spirina LV; Division of Biochemistry and Molecular Biology, Siberian State Medical University, Tomsk, Russian Federation.; Cancer Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russian Federation., Avgustinovich AV; Cancer Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russian Federation., Afanas'ev SG; Cancer Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russian Federation., Volkov MY; Cancer Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russian Federation., Azovsky DI; Cancer Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russian Federation., Volkov AM; Cancer Research Institute, Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk, Russian Federation., Klyushina TS; Division of Biochemistry and Molecular Biology, Siberian State Medical University, Tomsk, Russian Federation.
Jazyk:	angličtina
Zdroj:	Current drug targets [Curr Drug Targets] 2024; Vol. 25 (11), pp. 715-723.
DOI:	10.2174/0113894501304351240703113651
Abstrakt:	The main epidemiological and clinical data on colorectal cancer, as well as the features of molecular pathology, are discussed in the literature review. Efforts are being putto identify promising targets, particularly small non-coding nucleotide sequences, which can lead to new treatments for this disease. The discovery of significant mutations that contribute to the development of colorectal tumors is a major step in the advancement of molecular oncology, as these mutations give rise to heterogeneous tumors that differ in their origin. These mutations play a significant role in the progression of the disease and are now being targeted for treatment. The prognosis for a disease is influenced by the patient's sensitivity to antitumor therapy. However, new approaches to finding effective targets for antitumor treatments face new fundamental challenges due to clinical issues. These issues include the epigenetic regulation of markers of oncogenesis, which allows for the development of new therapeutic strategies. RNA interference, in particular, has been linked to non-copying RNA sequences such as microRNAs. These microRNAs are associated with certain processes that can influence all aspects of oncogenesis. The diversity of microRNAs allows for a differentiated approach when treating tumors in various locations. (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu